Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

AVIRAVIR
Showing 8 of 23 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ATEA PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 2M shares of AVIR (ATEA PHARMACEUTICALS INC), worth $9.1M as of 2026-Q2. The position was increased (+12.1% shares). AVIR represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$9.1M

Current Shares

2M

Total Value Change

+$2.7M

Total Shares Change

+33,662

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+12.1%
$9.1M0.0%$4.65
31
2026-Q1
Decreased
1.7M
-5.1%
$9.4M0.0%$4.82
0
2025-Q4
Decreased
1.8M
-3.1%
$6.6M0.0%$3.55
0
2025-Q3
Decreased
1.9M
-1.3%
$5.5M0.0%$2.92
0
2025-Q2
Decreased
1.9M
-2.6%
$6.9M0.0%$3.45
0
2025-Q1
Increased
2M
+3.2%
$5.9M0.0%$2.93
28
2024-Q4
Decreased
1.9M
-0.4%
$6.4M0.0%$3.33
0
2024-Q3
Decreased
1.9M
-4.2%
$6.4M0.0%$3.44
0

Other major holders of AVIR: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used